Composite Ratios Boost CRP's Power in Monitoring Ulcerative Colitis.
NCT ID: NCT07261579
Last Updated: 2026-01-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
80 participants
OBSERVATIONAL
2025-09-15
2025-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Role of C-Reactive Protein /Albumin Ratio in Evaluation of Disease Activity in Patients With Inflammatory Bowel Disease
NCT05738915
Comparing the Accuracy of Different Ultrasound-based Scores to Assess Disease Severity in Patients with Inflammatory Bowel Disease
NCT06705972
Value Of ACE Index (Albumin, CRP And Endoscopy) In Predicting Intra Venous Steroid Response In Acute Severe Ulcerative Colitis In Assiut University Hospitals
NCT06267651
Value of Fecal Calprotectin
NCT00577928
Novel Biomarkers in Inflammatory Bowel Disease
NCT03833310
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ulcerative Colitis Patients
Patients exhibiting clinical signs suggestive of IBD were assessed for UC diagnostic criteria, and the study inclusion and exclusion standards.
C-Reactive Protein measuring CRP
5-ml peripheral blood samples were aseptically obtained for a complete blood count, and ELISA estimation of serum CRP
CRP to Albumin Ratio
Serum CRP to albumin ratio (CAR) is a combination of markers for systemic inflammation and nutritional status
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
C-Reactive Protein measuring CRP
5-ml peripheral blood samples were aseptically obtained for a complete blood count, and ELISA estimation of serum CRP
CRP to Albumin Ratio
Serum CRP to albumin ratio (CAR) is a combination of markers for systemic inflammation and nutritional status
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients who was Previously diagnosed with IBD or IBS;
* Patients with recurrence of manifestations after surgical resection;
* Patients who refused to sign the participation consent.
18 Years
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Benha University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Raafat R. Mohammed
Assistant consultant of Clinical Pathology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alexandria Faculty of medicine
Alexandria, El Alexandria, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
E/C. S/N. R14/2025
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.